Lactulose Dosage Recommendations
For adults with hepatic encephalopathy, initiate lactulose at 30-45 mL (20-30 grams) orally every 1-2 hours until achieving 2-3 soft bowel movements daily, then titrate to maintain this frequency; for children, start with 2.5-10 mL daily for infants and 40-90 mL daily for older children/adolescents in divided doses. 1
Adult Dosing
Initial Treatment for Overt Hepatic Encephalopathy
- Acute phase: Administer 30-45 mL (2-3 tablespoonfuls) every 1-2 hours until rapid laxation occurs 1
- Once laxative effect achieved, reduce to maintenance dosing
- Improvement may occur within 24 hours but can take 48 hours or longer 1
Maintenance Dosing
- Standard dose: 30-45 mL three to four times daily 1
- Target: 2-3 soft bowel movements per day 2, 3, 1
- Adjust dose every 1-2 days to achieve target bowel frequency 1
Secondary Prophylaxis
Following a first episode of overt HE, lactulose should be continued long-term and titrated to maintain 2-3 bowel movements daily 2. This reduces HE recurrence risk from 47% to 20% over 14 months 2.
Pediatric Dosing
Age-based approach 1:
- Infants: 2.5-10 mL daily in divided doses
- Older children and adolescents: 40-90 mL total daily dose
- If initial dose causes diarrhea, reduce immediately
- If diarrhea persists, discontinue lactulose 1
Rectal Administration
For patients unable to take oral medication (impending coma, aspiration risk, or physical interference from procedures) 1:
- Mix 300 mL lactulose with 700 mL water or physiologic saline
- Administer as retention enema via rectal balloon catheter
- Retain for 30-60 minutes
- May repeat every 4-6 hours
- Avoid alkaline cleansing enemas (soap suds contraindicated) 1
- Transition to oral dosing once coma reverses 1
Dose Adjustments in Organ Impairment
Hepatic Impairment
No dose adjustment required - lactulose is the primary treatment for hepatic encephalopathy regardless of liver disease severity 2, 3. The medication works locally in the gut and is minimally absorbed systemically.
Renal Impairment
Mild to moderate renal impairment: No dose adjustment necessary 4, 5
- Lactulose is 83.6% removed by hemodialysis 4
- Multiple doses coordinated with dialysis show no plasma accumulation 4
- Studies demonstrate safe use in CKD stages 3-4 at standard dosing (30 mL three times daily) 5
Hemodialysis patients: Standard dosing can be used safely 4
- Pharmacokinetic studies show good tolerability
- Coordinate dosing with dialysis schedule to prevent accumulation
- Monitor for diarrhea (most common adverse effect) 4
Critical Dosing Pitfalls
Overuse Complications
Avoid excessive dosing - this is a common misconception that larger doses overcome lack of effect 3. Overuse causes:
- Aspiration risk
- Dehydration
- Hypernatremia
- Severe perianal skin irritation
- Paradoxical precipitation of HE 3
Inadequate Response
If lactulose fails at appropriate dosing, search for:
- Unrecognized precipitating factors
- Competing causes of brain impairment 3
- Consider adding rifaximin if patient has >1 additional HE episode within 6 months 2
Monitoring Parameters
- Bowel movement frequency (target: 2-3 soft stools daily)
- Hydration status
- Electrolytes (sodium particularly)
- Mental status improvement
- Avoid concurrent use with alkaline agents 1